ArticleNPJ digital medicine2025
Large language models driven neural architecture search for universal and lightweight disease diagnosis on histopathology slide images.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CT-based AI system for quantitative and integrated management of acute respiratory distress syndrome in critical care.NPJ digital medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Artificial Intelligence has revolutionized healthcare by offering smart services and reducing diagnostic burden, particularly facilitating the identification and segmentation of malignant tissues. However, current task-specific approaches require disease-specific models, while universal foundation models demand costly customization for complex cases, hindering practical deployment in clinical environments. We present Pathology-NAS, a universal and lightweight medical analysis framework that leverages LLMs' knowledge to refine the architecture space across diverse scenarios, eliminating the need for exhaustive search. Pathology-NAS is pretrained on 1.3 million images across three supernet architectures, providing a robust visual foundation that generalizes across diverse tasks. Across breast cancer and diabetic retinopathy diagnosis tasks, Pathology-NAS achieves 99.98% classification accuracy while reducing FLOPs by 45% compared to leading methods. Our model delivers near-optimal architectures in just 10 iterations, bypassing the exponential search space. Pathology-NAS provides accurate tumor recognition across diverse tissues with computational efficiency, making AI-assisted diagnosis practical even in resource-constrained clinical environments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.